These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 22805767)
1. Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Li Y; Kong D; Ahmad A; Bao B; Dyson G; Sarkar FH Epigenetics; 2012 Aug; 7(8):940-9. PubMed ID: 22805767 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Ramalho-Carvalho J; Martins JB; Cekaite L; Sveen A; Torres-Ferreira J; Graça I; Costa-Pinheiro P; Eilertsen IA; Antunes L; Oliveira J; Lothe RA; Henrique R; Jerónimo C Cancer Lett; 2017 Jan; 385():150-159. PubMed ID: 27984115 [TBL] [Abstract][Full Text] [Related]
3. miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer. Pasqualini L; Bu H; Puhr M; Narisu N; Rainer J; Schlick B; Schäfer G; Angelova M; Trajanoski Z; Börno ST; Schweiger MR; Fuchsberger C; Klocker H Mol Endocrinol; 2015 Jul; 29(7):1037-54. PubMed ID: 26052614 [TBL] [Abstract][Full Text] [Related]
5. Regulation of miR-200c and miR-141 by Methylation in Prostate Cancer. Lynch SM; O'Neill KM; McKenna MM; Walsh CP; McKenna DJ Prostate; 2016 Sep; 76(13):1146-59. PubMed ID: 27198154 [TBL] [Abstract][Full Text] [Related]
6. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363 [TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of epi-miRNA expression levels in local/locally advanced and metastatic prostate cancer patients. Gurbuz V; Kiliccioglu I; Dikmen AU; Bilen CY; Sozen S; Konac E Gene; 2020 Oct; 758():144963. PubMed ID: 32683077 [TBL] [Abstract][Full Text] [Related]
8. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Miyajima N; Maruyama S; Bohgaki M; Kano S; Shigemura M; Shinohara N; Nonomura K; Hatakeyama S Cancer Res; 2008 May; 68(9):3486-94. PubMed ID: 18451177 [TBL] [Abstract][Full Text] [Related]
9. Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancer. Goto Y; Kojima S; Kurozumi A; Kato M; Okato A; Matsushita R; Ichikawa T; Seki N Br J Cancer; 2016 May; 114(10):1135-44. PubMed ID: 27070713 [TBL] [Abstract][Full Text] [Related]
10. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer. Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691 [TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer. Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963 [TBL] [Abstract][Full Text] [Related]
12. Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193. Pan Y; Zhang R; Chen H; Chen W; Wu K; Lv J Med Sci Monit; 2019 Jan; 25():98-106. PubMed ID: 30608062 [TBL] [Abstract][Full Text] [Related]
13. Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer. Kato M; Kurozumi A; Goto Y; Matsushita R; Okato A; Nishikawa R; Fukumoto I; Koshizuka K; Ichikawa T; Seki N J Hum Genet; 2017 Jan; 62(1):123-132. PubMed ID: 27278788 [TBL] [Abstract][Full Text] [Related]
14. Circular RNA Myosin Light Chain Kinase (MYLK) Promotes Prostate Cancer Progression through Modulating Mir-29a Expression. Dai Y; Li D; Chen X; Tan X; Gu J; Chen M; Zhang X Med Sci Monit; 2018 May; 24():3462-3471. PubMed ID: 29798970 [TBL] [Abstract][Full Text] [Related]
15. miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines. Zhu C; Li J; Ding Q; Cheng G; Zhou H; Tao L; Cai H; Li P; Cao Q; Ju X; Meng X; Qin C; Hua L; Shao P; Yin C Prostate; 2013 Jul; 73(10):1082-9. PubMed ID: 23460133 [TBL] [Abstract][Full Text] [Related]
16. Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential. Almeida M; Costa VL; Costa NR; Ramalho-Carvalho J; Baptista T; Ribeiro FR; Paulo P; Teixeira MR; Oliveira J; Lothe RA; Lind GE; Henrique R; Jerónimo C J Cell Mol Med; 2014 Nov; 18(11):2287-97. PubMed ID: 25211630 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of miRNAs and methylation of their promoters are correlated in neuroblastoma. Maugeri M; Barbagallo D; Barbagallo C; Banelli B; Di Mauro S; Purrello F; Magro G; Ragusa M; Di Pietro C; Romani M; Purrello M Oncotarget; 2016 Dec; 7(50):83330-83341. PubMed ID: 27829219 [TBL] [Abstract][Full Text] [Related]
18. Demethylation of miR-195 suppresses prostate cancer cell proliferation, migration and invasion. Ma X; Zou L; Chen Z; Li X; Wei L; Wu X FEBS Open Bio; 2020 Apr; 10(4):525-534. PubMed ID: 31977154 [TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-191 promotes cell growth and invasion via targeting TIMP3 in prostate cancer. Wang X; Shi Z; Liu X; Su Y; Li W; Dong H; Zhao L; Li M; Wang Y; Jin X; Huo Z J BUON; 2018; 23(2):444-452. PubMed ID: 29745091 [TBL] [Abstract][Full Text] [Related]
20. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Majid S; Dar AA; Saini S; Shahryari V; Arora S; Zaman MS; Chang I; Yamamura S; Tanaka Y; Chiyomaru T; Deng G; Dahiya R Clin Cancer Res; 2013 Jan; 19(1):73-84. PubMed ID: 23147995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]